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Mucosa-associated lymphoid tissue (MALT) lymphoma is the third most common non-Hodgkin lymphoma, and it is strongly
associated with helicobacter pylori infection of the stomach. MALT lymphoma of the lacrimal gland usually presents as a localized
disease process in extranodal tissues. The treatment options of MALT lymphoma of the lacrimal gland chieﬂy include radiation of
the tumor, chemotherapy, surgical removal, or a combination of these strategies. We report a case of localized MALT lymphoma
of the lacrimal gland, with prolonged sustained remission after eradication of gastric Helicobacter pylori (H. Pylori) infection. He
sustains in remission of lacrimal MALT lymphoma for four years without chemotherapy or radiotherapy.
1.Introduction
Mucosa-associated lymphoid tissue (MALT) lymphoma is
the third most common non-Hodgkin lymphoma subtype,
accountingforaround6–8%ofallnon-Hodgkinlymphomas
[1]. Extranodal marginal zone B-cell lymphoma (EMZBL)
also referred to as MALT lymphoma of the lacrimal gland is
a rare condition [2]. The stomach is the most frequent site of
involvement by EMZBL, followed by salivary glands, orbit,
lung, and skin.
H. pylori infection of the stomach is recognized as a
causative agent of gastritis, ulcer disease, gastric carcinoma
and MALT lymphoma [3].
The treatment options of MALT lymphoma of the lacri-
mal gland chieﬂy include radiation of the tumor, chemo-
therapy, surgical removal, or a combination of these strate-
gies [4].
The present paper describes a 6-year-old boy with MALT
lymphoma of the lacrimal gland with sustained remission
after eradication of gastric H. pylori infection and without
chemotherapy or radiotherapy. A review of the literature is
also provided.
2.CaseReport
A 6-year-old boy presented with lacrimal sac swelling for
furtherinvestigation.Thepatientwasnoticedtohaveaswell-
ing at the left nasal aspect for the last 3 months. It increased
gradually in size associated of excessive tearing. There was
no history of fever, weight loss, and change in appetite or2 Case Reports in Gastrointestinal Medicine
Figure 1:PET-CTofwholebodyshowstworightandoneleftsmall
hypermetabolic nodal lesions in the upper jugulodigastric area
(black arrows). They are reactive in nature, otherwise negative scan.
activity. No history of night sweat, skin rash, joint pain, re-
cent travel. Medical history was otherwise noncontributory.
The family revealed no history of malignancy. The patient
had normal developmental milestones. He was not taking
medications.
On admission to hospital, the physical examination re-
vealed no evidence of growth retardation and a fullness over
the left lacrimal sac area; otherwise extraocular motility was
full with minimal ptosis. Irrigation of the lacrimal system
was negative. Cornea, anterior chamber, and lens were clear
onbothsides.Nohepatosplenomegaly,lymphadenopathy,or
skin rashes were noted. Physical systemic examination was
otherwise unremarkable.
The laboratory ﬁndings revealed normal haemoglobin,
white blood cell, and platelet counts. The electrolytes,
coagulationstudy,liverfunctiontests,Lactatedehydrogenase
(LDH), and peripheral blood smear results were normal.
Cerebrospinal ﬂuid studies revealed no blast cells.
Bone marrow studies (aspirate, biopsy, clot section, and
iron stain) showed normocellular active bone marrow with
no evidence of inﬁltration by lymphoma or any other
malignancy.
A computed tomography (CT) scan revealed a soft tissue
mass located and extended out of the left lacrimal sac
with enhanced posterior encroachment into the orbit. CT
scan revealed that bilateral enlarged cervical lymph nodes
otherwise the brain, orbit, chest, abdomen, and pelvis
were normal. Magnetic resonance imaging (MRI) showed
Dacryocystocele.
Positron emission tomography-computed tomography
(PET-CT) scan demonstrated two right and one left small
hypermetabolic nodal lesions in the upper jugulodigastric
area (Figure 1).
A surgical dacryocystorhinostomy was performed. The
exploration of lacrimal sac revealed a full sac of tumor with
indistinct walls and posterior extension of the tumor to the
50mm
Figure 2: Hematoxylin and Eosin (H&E) stain shows Monotonous
lymphoid inﬁltrate with medium size nuclei.
50mm
Figure 3: CD 20 immunoreactive lymphoid inﬁltrate—MALT B-
cell lymphoma. Clonality conﬁrmed by immunoglobulin heavy
(IGH) gene rearrangement studies favored B-cell extranodal
marginal zone lymphoma (MALT type).
orbit. Remnants of the tumor in the posterior aspect were
not removed totally.
Immunohistochemistry revealed atypical lymphoid
inﬁltrate consistent with B-cell non-Hodgkin lymphoma
(Figure 2). Clonality conﬁrmed by immunoglobulin heavy
(IGH) gene rearrangement studies favored B-cell extranodal
m a r g i n a lz o n el y m p h o m a( M A L Tt y p e )( Figure 3).
Combined chemotherapy and radiotherapy was planned
after surgery to eradicate the remnants of the tumor in the
posterior aspect, but the family refused the treatment.
The patient was referred to Gastroenterology clinic for
looking to H. pylori infection of the stomach. He had
no gastrointestinal symptoms. Esophagogastroduodenosco-
py was performed. Antral nodularity was discovered. Cam-
pylobacter-like organism (CLO) test was positive. Multiple
biopsies from the antrum and body of the stomach demon-
strated chronic active gastritis with heavy helicobacter pylori
organisms; no gastric metaplasia, dysplasia, or malignancy.Case Reports in Gastrointestinal Medicine 3
The patient received both Amoxicillin 500mgq12 hour and
Clarithromycin250mgq12hourfortwoweeksinadditionto
Esmoprazole 20mgq12 hour for two months. Two following
post therapy, stool antigen for H. pylori was negative. Six
months after therapy, stool antigen for helicobacter pylori was
also negative.
12 months later the lacrimal gland tumor was no longer
visible on MRI, and the patent had no tearing or ptosis.
His eye movement was full, and vision was 20/20 bilaterally
without correction.
No extraorbital manifestation of the MALT lymphoma
occurred during the subsequent follow-up period of four
years.
3. Discussion
Mucosa-associated lymphoid tissue (MALT) lymphomas are
composed of morphologically heterogeneous small B cells
and sometimes plasma cells growing in marginal zones
and interfollicular areas [5]. They predominantly occur in
older patients and are extremely rare in children and young
adults. Among 2,703 children and adolescents registered into
the prospective multicenter NHL-BFM treatment studies
since 1986, only 4 patients (0.1%) displayed features of
MALT lymphoma [6]. MALT lymphoma in the pediatric
population has been mainly described in patients with
human immunodeﬁciency virus infection [7], but some
isolated case reports of patients with MALT lymphoma
and without evidence of immunodeﬁciency have also been
published [8]. MALT lymphoma of ocular adnexa arises in
the orbit, conjunctiva, eyelids, and lacrimal gland.
The gastrointestinal tract is the most frequent site of
extranodal lymphoma, and the stomach is involved in up
to two-thirds of these cases, accounting for 30%–45% of all
extranodal lymphoma [9].
The relationship between H. pylori and gastric MALT
lymphoma is well established and also is thought to play a
role in the pathogenesis of conjunctival MALT lymphoma
and other nongastric lymphoma [10].
The pathogenesis of H. pylori and lacrimal MALT
lymphoma is not clear.
MALT lymphomas arise at sites of chronic antigenic
stimulation [11] due to autoimmunity (e.g., Hashimoto thy-
roiditis) or infections (such as H. pylori-associated chronic
gastritis) [12]. The chronic antigen stimulation hypothesis
holds that a speciﬁc infectious agent initiates a reactive
lymphoid inﬁltrate in the normally sterile ocular adnexal
tissues. This ultimately leads to a B-cell clonal expansion
and proliferation. At this stage, genetic alterations and
microenvironment may sustain the growth independent of
the infectious agent.
There is a linkage between infection with H. pylori
and chronic atrophic gastritis, an inﬂammatory precursor
of gastric adenocarcinoma [13]. Additionally, regression
of gastric MALT lymphoma after eradication of H. pylori
infectionwithantibioticsisalsoconsistentwiththispostulate
[14].Recently,similarregressionofdiseasehasbeenreported
in ocular adnexal MALT lymphoma after treatment with
antibiotics against Chlamydia psittaci [15].
Few data is found on the eﬀect of possible eradication of
H. pylori infection on MALT lymphoma of lacrimal gland.
Ferreri et al. [15] demonstrate the rates of H. pylori gastric
infection in patients with ocular adnexal lymphoma. Out of
the 31 patients with ocular adnexal MALT lymphoma, 10
(32%) have gastric H. pylori, and 4 are treated with H. pylori-
eradicating antibiotics exclusively [15]. The ocular adnexal
MALT lymphoma in these patients shows no response; six
receive H. pylori-eradicating antibiotics concurrently with
other therapies (doxycycline, rituximab, or orbit irradiation)
achieving lymphoma regression in all cases.
Gruenberger et al. [16] demonstrate case series of 45
patients with MALT lymphoma of the ocular adnexa; 15/39
(38%) have H. pylori infection.
Decaudin et al. [17] have examined a large series of
gastric biopsies for H. pylori in three cohorts of patients: (A)
patients with ocular adnexal lymphoma (OAL) (n = 83);
(B) patients with extragastric and extraophthalmologic lym-
phoma (n = 101); and (C) patients with no clinical evidence
of lymphoma (controls; n = 156). Gastric H. pylori infection
was investigated by means of histopathological analysis and
H. pylori-speciﬁc polymerase chain reaction (PCR) assay on
gastric biopsy tissue samples and was demonstrated in 45%,
25%, and 12% of patients in groups (A), (B), and (C),
respectively. That is, a signiﬁcant association between gastric
H. pylori infection and OAL could be demonstrated in this
study, with this association being greatest for EMZBL group
of OAL. This association with gastric H. pylori infection
was not seen in other subtypes of OAL. Decaudin et al.
propose that gastric H. pylori infection results in the initial
malignant transformation of the lymphocytes and that these
neoplastic B cells subsequently migrate to the ocular adnexa,
here forming “ectopic lymphoma.” The migration process is
suggested to be as a result of cellular homing mechanisms
with chemotactic agents being released by localised chronic
inﬂammation in the ocular adnexal tissues.
Our patient and Decaudin et al. data [17] would suggest
that lacrimal MALT lymphoma patients should be examined
for gastric H. pylori infection following lymphoma diagnosis
and that, if positive, antibacterial treatment for H. pylori
could possibly result in the disappearance of an EMZBL
or MALT lymphoma of the lacrimal gland if treated early
enough, as seen in gastric MALT lymphomas.
While chemotherapy and/or radiotherapy is the role for
cureinadultMALTlymphoma,childhoodMALTlymphoma
tends to follow an indolent course, and remission could be
attained with eradication of H. pylori [18].
Our case with lacrimal MALT lymphoma after eradi-
cation of H. pylori infection has prolonged remission for
four years without chemotherapy or radiotherapy, similar
to Berrebi et al. [19] in which reports one case of MALT
lymphoma arising in a minor salivary gland in a patient
with gastric H. pylori infection, which resolves following
treatment of the gastric infection.
4. Conclusion
We believe that there is possible new role for H. Pylori
in the development of MALT lymphoma of the lacrimal4 Case Reports in Gastrointestinal Medicine
gland because H. pylori eradication allows prolonged remis-
sion of lacrimal MALT lymphoma for four years without
chemotherapyorradiotherapy. We suggestthatthe examina-
tionforgastricH.pyloriinfectioncanbeonetheoftreatment
modalities of MALT lymphoma of the lacrimal gland.
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